 VANCOUVER, British Columbia SEATTLE--BUSINESS WIRE--Zymeworks Inc. NYSE: ZYME, a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, today announced that management will participate in an upcoming investor conference: Jefferies Healthcare Conference. Zymeworks will participate in one-on-one meetings on June 8th 9th and will present on June 8th at 9:30 a.m. ET in New York, NY. The presentation will be available on Zymeworks website at htt 